March 4, 2026
Appoints Frederik Decouttere as CEO LAUSANNE, Switzerland -- Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several [...]
March 4, 2026
Contributing to Cancer Research with Technology that Visualizes Multi-layered Omics Information on Microscopic Images Superimposing multiple spatial omics information onto a microscopic image TOKYO – Nikon Corporation (Nikon) is pleased to announce that its software technology, developed to visualize multiple layers of spatial omics information *1 on microscopic images, was used in joint research led by [...]
March 4, 2026
MONMOUTH JUNCTION, N.J. -- TheWell Bioscience, a leader in advanced xeno-free cell culture technologies, today announced the launch of RocketCell™ hMSC Xeno-Free Complete Growth Medium, a chemically defined, xeno-free medium engineered for high-performance human mesenchymal stem cell (hMSC) expansion and exosome production across research, translational development, and cell therapy manufacturing workflows. As regulatory agencies and industry [...]
March 4, 2026
MADISON, Wis. -- BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies in pain biology, sensory transduction, and ion channel pharmacology. BrainXell sensory neurons demonstrate robust expression of hallmark sensory neuron genes and proteins, including voltage-gated sodium channels [...]
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
March 4, 2026
BURLINGTON, Mass. -- Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash [...]
Sartorius launches rational-design CHO host cell line with up to three-fold increase in productivity
March 3, 2026
New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold increase in productivity Host provides robust, long-term genetic and phenotypic stability, supporting reliable performance and providing greater confidence through scale-up and regulatory milestones Göttingen, Germany -- Sartorius is addressing the increasing demand for faster and more efficient [...]
March 3, 2026
NATICK, Mass. -- Pillar Biosciences today announced the launch of the oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate key acute myeloid leukemia (AML) genomic results more efficiently. AML is an aggressive hematologic malignancy where molecular characterization can be time-sensitive in research settings for operational workflow and investigational assessment. The [...]
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
March 3, 2026
Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services BELTSVILLE, Md. -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs). Operating from its Beltsville, Maryland facility, REPROCELL now offers a comprehensive, end-to-end workflow for [...]
Pall Corporation Appoints Dr. Roland Folz as President
March 3, 2026
PORT WASHINGTON, N.Y. – Pall Corporation, a Danaher company and a global leader in filtration, separation and purification, announced the appointment of Dr. Roland Folz as President, Pall Corporation, effective March 3, 2026. As President, Dr. Folz will lead Pall’s global business and set the company’s strategic direction, working closely with the leadership team to [...]
BC Platforms launches next generation trusted research environment on AWS Marketplace
March 3, 2026
Zurich – BC Platforms, a global leader in healthcare data, technology, and analytics today announced enhancements to BC Mosaic, its AI-powered trusted research environment (TRE), now available on AWS Marketplace. Featuring an all-new, intuitive user interface, BC Mosaic enables secure, compliant analysis of complex clinical, real-world, and multi-omics data within a single trusted research environment. Designed to make trusted [...]

